Patents by Inventor Philip T. Pienkos
Philip T. Pienkos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11820876Abstract: The present disclosure relates to a method for making a non-isocyanate polyurethane (NIPU) foam, where the method includes decomposing a blowing agent having at least one of an amine carbamate salt and/or an amine bicarbonate salt to form a diamine and CO2 in the presence of a molecule comprising a plurality of cyclic carbonate functional groups and reacting the diamine with at least a portion of the cyclic carbonate functional groups to form the NIPU foam. In some embodiments of the present disclosure, the reacting and the decomposing may occur at substantially the same rate.Type: GrantFiled: August 10, 2021Date of Patent: November 21, 2023Assignee: Alliance for Sustainable Energy, LLCInventors: Tao Dong, Philip T. Pienkos
-
Publication number: 20220041830Abstract: The present disclosure relates to a method for making a non-isocyanate polyurethane (NIPU) foam, where the method includes decomposing a blowing agent having at least one of an amine carbamate salt and/or an amine bicarbonate salt to form a diamine and CO2 in the presence of a molecule comprising a plurality of cyclic carbonate functional groups and reacting the diamine with at least a portion of the cyclic carbonate functional groups to form the NIPU foam. In some embodiments of the present disclosure, the reacting and the decomposing may occur at substantially the same rate.Type: ApplicationFiled: August 10, 2021Publication date: February 10, 2022Inventors: Tao DONG, Philip T. PIENKOS
-
Publication number: 20210347949Abstract: The present disclosure relates to methods for producing polymers and resins, the method including a first reacting of at least a first diamine with a first carbonate-containing compound and a second carbonate-containing compound to produce at least one of the polymer or the resin, where the first reacting is according to each of R1, R2, R3, and R4 include at least one of a hydrogen atom, a methyl group, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain, and R comprises at least one of a carbon atom, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain.Type: ApplicationFiled: July 22, 2021Publication date: November 11, 2021Inventors: Tao DONG, Lieve M.L. LAURENS, Philip T. PIENKOS, Paris Fabian SPINELLI
-
Publication number: 20210347948Abstract: The present disclosure relates to methods for producing polymers and resins, the method including a first reacting of at least a first diamine with a first carbonate-containing compound and a second carbonate-containing compound to produce at least one of the polymer or the resin, where the first reacting is according to each of R1, R2, R3, and R4 include at least one of a hydrogen atom, a methyl group, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain, and R comprises at least one of a carbon atom, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain.Type: ApplicationFiled: July 22, 2021Publication date: November 11, 2021Inventors: Tao DONG, Lieve M.L. LAURENS, Philip T. PIENKOS, Paris Fabian SPINELLI
-
Patent number: 11104763Abstract: The present disclosure relates to methods for producing polymers and resins, the method including a first reacting of at least a first diamine with a first carbonate-containing compound and a second carbonate-containing compound to produce at least one of the polymer or the resin, where the first reacting is according to each of R1, R2, R3, and R4 include at least one of a hydrogen atom, a methyl group, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain, and R comprises at least one of a carbon atom, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain.Type: GrantFiled: April 6, 2018Date of Patent: August 31, 2021Assignee: Alliance for Sustainable Energy, LLCInventors: Tao Dong, Lieve M. L. Laurens, Philip T. Pienkos, Paris Fabian Spinelli
-
Publication number: 20200017638Abstract: The present disclosure relates to methods for producing polymers and resins, the method including a first reacting of at least a first diamine with a first carbonate-containing compound and a second carbonate-containing compound to produce at least one of the polymer or the resin, where the first reacting is according to each of R1, R2, R3, and R4 include at least one of a hydrogen atom, a methyl group, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain, and R comprises at least one of a carbon atom, a saturated hydrocarbon chain, and/or an unsaturated hydrocarbon chain.Type: ApplicationFiled: April 6, 2018Publication date: January 16, 2020Inventors: Tao DONG, Lieve M.L. LAURENS, Philip T. PIENKOS, Paris FABIAN SPINELLI
-
Patent number: 10266852Abstract: Disclosed herein are methods for the production of fuels, chemicals, or materials from biomass-derived lignin, cellulose, and hemicellulose. Also provided are methods for the production of polyhydroxyalkanoates from lignocellulosic biomass and the subsequent thermal and catalytic conversion of polyhydroxyalkanoates to hydrocarbons. In addition, methods for the production of ethanol from the fermentation of polysaccharides are described.Type: GrantFiled: December 8, 2014Date of Patent: April 23, 2019Assignees: Alliance for Sustainable Energy, LLC, The Board of Trustees of the University of IllinoisInventors: Gregg T. Beckham, Jeffrey G. Linger, Derek R. Vardon, Michael T. Guarnieri, Eric M. Karp, Mary Ann Franden, Christopher W. Johnson, Timothy J. Strathmann, Philip T. Pienkos
-
Publication number: 20180371502Abstract: Disclosed herein are methods for the production of fuels, chemicals, or materials from biomass-derived lignin, cellulose, and hemicellulose. Also provided are methods for the production of polyhydroxyalkanoates from lignocellulosic biomass and the subsequent thermal and catalytic conversion of polyhydroxyalkanoates to hydrocarbons. In addition, methods for the production of ethanol from the fermentation of polysaccharides are described.Type: ApplicationFiled: December 8, 2014Publication date: December 27, 2018Inventors: Gregg T. BECKHAM, Jeffrey G. LINGER, Derek R. VARDON, Michael T. GUARNIERI, Eric M. KARP, Mary Ann FRANDEN, Christopher W. JOHNSON, Timothy J. STRATHMANN, Philip T. PIENKOS
-
Patent number: 9206445Abstract: Disclosed herein are biocatalysts for the production of biofuels, including microorganisms that contain genetic modifications conferring tolerance to growth and fermentation inhibitors found in many cellulosic feedstocks. Methods of converting cellulose-containing materials to fuels and chemicals, as well as methods of fermenting sugars to fuels and chemicals, using these biocatalysts are also disclosed.Type: GrantFiled: April 29, 2014Date of Patent: December 8, 2015Assignee: Alliance for Sustainable Energy, LLCInventors: Shihui Yang, Jeffrey Linger, Mary Ann Franden, Philip T. Pienkos, Min Zhang
-
Publication number: 20140342421Abstract: Disclosed herein are biocatalysts for the production of biofuels, including microorganisms that contain genetic modifications conferring tolerance to growth and fermentation inhibitors found in many cellulosic feedstocks. Methods of converting cellulose-containing materials to fuels and chemicals, as well as methods of fermenting sugars to fuels and chemicals, using these biocatalysts are also disclosed.Type: ApplicationFiled: April 29, 2014Publication date: November 20, 2014Applicant: Alliance for Sustainable Energy, LLCInventors: Shihui YANG, Jeffrey LINGER, Mary Ann FRANDEN, Philip T. PIENKOS, Min ZHANG
-
Publication number: 20090318350Abstract: The present invention features human epidermal receptor (HER) antagonists. These antagonists are polypeptide variants of ligands of HER. The HER ligand polypeptide variants of the invention possess Pan-HER antagonistic properties and can inhibit at least one HER-mediated biological activity of one or more HER subtypes, such as inhibition of the receptor's kinase activation activity and subsequently, cell proliferation. Such polypeptide variants, and nucleic acids encoding these polypeptide variants can be used therapeutically in situations in which inhibition of HER activity is indicated.Type: ApplicationFiled: March 5, 2009Publication date: December 24, 2009Inventors: Philip T. Pienkos, Daniel J. Monticello
-
Publication number: 20090311783Abstract: The present invention relates to IGF-I variants that bind to the Insulin-like Growth Factor Receptor I (IGF-IR) but do not initiate signal transduction and the subsequent metabolic, growth and anti-apoptotic activities associated with this molecule and the progression of cancer. These novel variants act to block the binding of the cognate ligands but do not bind to the insulin receptor.Type: ApplicationFiled: March 5, 2009Publication date: December 17, 2009Inventors: Philip T. Pienkos, Daniel J. Monticello
-
Publication number: 20090286729Abstract: The present invention features epidermal growth factor receptor (EGFR) antagonists. These EGFR antagonists are polypeptide variants of ligands of EGFR. The EGFR ligand polypeptide variants of the invention possess EGFR antagonistic properties and can inhibit at least one EGFR-mediated biological activity such as inhibition of the receptor's kinase activation activity and subsequently, cell proliferation. Such polypeptide variants, and nucleic acids encoding these polypeptide variants can be used therapeutically in situations in which inhibition of EGFR activity is indicated.Type: ApplicationFiled: October 30, 2008Publication date: November 19, 2009Inventors: Jeffrey S. Bishop, A. Katrina Loomis, Daniel J. Monticello, Philip T. Pienkos
-
Patent number: 7557181Abstract: The present invention features human epidermal receptor (HER) antagonists. These antagonists are polypeptide variants of ligands of HER. The HER ligand polypeptide variants of the invention possess Pan-HER antagonistic properties and can inhibit at least one HER-mediated biological activity of one or more HER subtypes, such as inhibition of the receptor's kinase activation activity and subsequently, cell proliferation. Such polypeptide variants, and nucleic acids encoding these polypeptide variants can be used therapeutically in situations in which inhibition of HER activity is indicated.Type: GrantFiled: June 30, 2005Date of Patent: July 7, 2009Assignee: Molecular Logix, Inc.Inventors: Philip T. Pienkos, Daniel J. Monticello
-
Patent number: 7470769Abstract: The present invention features epidermal growth factor receptor (EGFR) antagonists. These EGFR antagonists are polypeptide variants of ligands of EGFR. The EGFR ligand polypeptide variants of the invention possess EGFR antagonistic properties and can inhibit at least one EGFR-mediated biological activity such as inhibition of the receptor's kinase activation activity and subsequently, cell proliferation. Such polypeptide variants, and nucleic acids encoding these polypeptide variants can be used therapeutically in situations in which inhibition of EGFR activity is indicated.Type: GrantFiled: June 30, 2005Date of Patent: December 30, 2008Assignee: Molecular Logix, Inc.Inventors: Jeffrey S. Bishop, A. Katrina Loomis, Daniel J. Monticello, Philip T. Pienkos